Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar 15;67(10):1186-1196.
doi: 10.1016/j.jacc.2015.12.042.

Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study

Affiliations
Randomized Controlled Trial

Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study

Gabriel C Brooks et al. J Am Coll Cardiol. .

Abstract

Background: Persistent severe left ventricular (LV) systolic dysfunction after myocardial infarction (MI) is associated with increased mortality and is a class I indication for implantation of a cardioverter-defibrillator.

Objectives: This study developed models and assessed independent predictors of LV recovery to >35% and ≥50% after 90-day follow-up in patients presenting with acute MI and severe LV dysfunction.

Methods: Our multicenter prospective observational study enrolled participants with ejection fraction (EF) of ≤35% at the time of MI (n = 231). Predictors for EF recovery to >35% and ≥50% were identified after multivariate modeling and validated in a separate cohort (n = 236).

Results: In the PREDICTS (PREDiction of ICd Treatment Study) study, 43% of patients had persistent EF ≤35%, 31% had an EF of 36% to 49%, and 26% had an EF ≥50%. The model that best predicted recovery of EF to >35% included EF at presentation, length of stay, prior MI, lateral wall motion abnormality at presentation, and peak troponin. The model that best predicted recovery of EF to ≥50% included EF at presentation, peak troponin, prior MI, and presentation with ventricular fibrillation or cardiac arrest. After predictors were transformed into point scores, the lowest point scores predicted a 9% and 4% probability of EF recovery to >35% and ≥50%, respectively, whereas profiles with the highest point scores predicted an 87% and 49% probability of EF recovery to >35% and ≥50%, respectively.

Conclusions: In patients with severe systolic dysfunction following acute MI with an EF ≤35%, 57% had EF recovery to >35%. A model using clinical variables present at the time of MI can help predict EF recovery.

Keywords: heart failure; remodeling; risk assessment; ventricular ejection fraction.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Frequency of EF Recovery ≥35%
The observed left ventricular functional recovery to an ejection fraction (EF) >35% 90 days after the index myocardial infarction improved as point score increased (n = number of participants in the derivation set).
Figure 2
Figure 2. Frequency of EF Recovery ≥50%
The observed left ventricular functional recovery to an EF ≥50% 90 days after the index myocardial infarction also improved as point score rose (n = number of participants in the derivation set). Abbreviations as in Figure 1.
Central Illustration
Central Illustration. Left Ventricular Dysfunction after Acute MI: Ejection Fraction 90 Days Acute Myocardial with Severe Systolic Dysfunction (EF ≤35%)
Severe left ventricular (LV) systolic dysfunction after myocardial infarction (MI) is associated with increased mortality. To better determine which patients with an ejection fraction (EF) ≤35% at time of acute MI may be more likely to improve systolic function, models assessing variables that predict LV recovery to an EF >35% and ≥50% 90 days after the event were developed. Although more patients continue to experience severe dysfunction, several variables predict partial or near normal recovery in these patients. VF = ventricular fibrillation.

Comment in

References

    1. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol. 2013;61:e6–e75. - PubMed
    1. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481–2488. - PubMed
    1. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427–1436. - PubMed
    1. Chia S, Senatore F, Raffel OC, et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008;1:415–423. - PubMed
    1. Hackel DB, Reimer KA, Ideker RE, et al. Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. Circulation. 1984;70:824–835. - PubMed

Publication types

MeSH terms